Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Non-Hodgkin Lymphoma, B-cell”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Large-scale testing (Phase 3)Looking for participantsNCT04332822
What this trial is testing

A Randomized, Multicenter, Phase III Trial Comparing Treatment With R-mini-CHOP With R-mini-CHP + Polatuzumab Vedotin in Patients With Diffuse Large Cell B Cell Lymphoma

Who this might be right for
DLBCLDiffuse Large B Cell Lymphoma
Nordic Lymphoma Group 300
Testing effectiveness (Phase 2)Study completedNCT00834951
What this trial is testing

Adjuvant Low Dose Total Body Irradiation in Elderly Patients With Diffuse Large B-Cell Lymphoma

Who this might be right for
Non Hodgkin's Lymphoma
University of Aarhus 40
Early research (Phase 1)Ended earlyNCT04804254
What this trial is testing

Study to Evaluate Adverse Events, Change in Disease Activity, Movement of Oral ABBV-623 and ABBV-992 Tablets in the Body of Adult Participants With B-cell Cancers

Who this might be right for
B-cell Lymphoma
AbbVie 5
Testing effectiveness (Phase 2)UnknownNCT05940051
What this trial is testing

Prospective Clinical Study of ZPR Regimen in Relapsed/Refractory Diffuse Large B-cell Lymphoma

Who this might be right for
Diffuse Large B Cell Lymphoma
Peng Liu 35
Testing effectiveness (Phase 2)UnknownNCT03837873
What this trial is testing

DLCL002 Protocol for Patients With High Risk Aggressive B-cell Lymphoma

Who this might be right for
Diffuse Large B Cell LymphomaHigh-grade B-cell LymphomaTransformed Lymphoma
Institute of Hematology & Blood Diseases Hospital, China 118
Early research (Phase 1)Study completedNCT00004002
What this trial is testing

PS-341 in Treating Patients With Advanced Solid Tumors or Lymphoma

Who this might be right for
LymphomaSmall Intestine CancerUnspecified Adult Solid Tumor, Protocol Specific
NYU Langone Health
Testing effectiveness (Phase 2)Looking for participantsNCT06486051
What this trial is testing

Atlacabtagene Autoleucel CAR T-cells for Adults With Relapsed Large B-cell Lymphoma

Who this might be right for
Large B-cell LymphomaDiffuse Large B-Cell Lymphoma, Not Otherwise SpecifiedPrimary Mediastinal Large B-cell Lymphoma (PMBCL)+1 more
Malaghan Institute of Medical Research 60
Testing effectiveness (Phase 2)UnknownNCT03467256
What this trial is testing

CD19 T-CAR for Treatment of Children and Young Adults With r/r B-ALL

Who this might be right for
B-cell Acute Lymphoblastic LeukemiaAcute Lymphocytic Leukemia, Pediatric
Federal Research Institute of Pediatric Hematology, Oncology and Immunology 18
Early research (Phase 1)WithdrawnNCT05037669
What this trial is testing

Programmed Allogeneic CRISPR-edited T Cells Engineered to Express Anti-CD19 Chimeric Antigen Receptor (PACE CART19) in Patients With Relapsed Or Refractory CD19+ Leukemia and Lymphoma

Who this might be right for
Acute Lymphoblastic LeukemiaChronic Lymphocytic LeukemiaNon Hodgkin Lymphoma
University of Pennsylvania
Testing effectiveness (Phase 2)Study completedNCT00005854
What this trial is testing

Bone Marrow Transplantation in Treating Patients With Hematologic Cancer

Who this might be right for
LeukemiaLymphomaMultiple Myeloma and Plasma Cell Neoplasm+1 more
Fred Hutchinson Cancer Center
Testing effectiveness (Phase 2)Looking for participantsNCT07410494
What this trial is testing

Biomarker-Guided Allogeneic Single-Target or Dual-Target CAR-NK Cell Therapy for Advanced Solid Tumors

Who this might be right for
CancerBreast CancerNon-Small Cell Lung Cancer (NSCLC)+10 more
Essen Biotech 85
Testing effectiveness (Phase 2)Ended earlyNCT05626322
What this trial is testing

Effects of Maplirpacept (PF-07901801),Tafasitamab, and Lenalidomide in People With Relapsed or Refractory Diffuse Large B-cell Lymphoma

Who this might be right for
Diffuse Large B-Cell Lymphoma
Pfizer 6
Not applicableLooking for participantsNCT06813573
What this trial is testing

Prospective Analysis of Circulating Nucleosomes in Patients Receiving a First Line Treatment for a Non-Hodgkin Lymphoma

Who this might be right for
Follicular LymphomaDiffuse Large B-Cell Lymphoma
Gustave Roussy, Cancer Campus, Grand Paris 50
Testing effectiveness (Phase 2)Ended earlyNCT03401853
What this trial is testing

Pembrolizumab With Rituximab or Obinutuzumab in Treating Patients With Relapsed or Refractory Follicular Lymphoma or Diffuse Large B Cell Lymphoma

Who this might be right for
Recurrent Diffuse Large B-Cell LymphomaRecurrent Follicular LymphomaRefractory Diffuse Large B-Cell Lymphoma+1 more
University of Washington 18
Large-scale testing (Phase 3)Looking for participantsNCT06764238
What this trial is testing

Newly-diagnosed Intermediate/High Risk Pediatric B-cell ALL Protocol

Who this might be right for
Acute Lymphoblastic Leukemia ALLChildhood Leukemia, Acute LymphoblasticB Cell Acute Lymphoblastic Leukemia (B-ALL)
Institute of Hematology & Blood Diseases Hospital, China 1,800
Early research (Phase 1)UnknownNCT01619761
What this trial is testing

NK Cells in Cord Blood Transplantation

Who this might be right for
Accelerated Phase Chronic Myelogenous Leukemia, BCR-ABL1 PositiveAcute Biphenotypic LeukemiaAcute Lymphoblastic Leukemia in Remission+22 more
M.D. Anderson Cancer Center 13
Testing effectiveness (Phase 2)Study completedNCT00004061
What this trial is testing

Biological Therapy in Treating Patients Undergoing Radiation Therapy, Chemotherapy, and Peripheral Stem Cell Transplantation for Hematologic Cancer

Who this might be right for
LeukemiaLymphomaOral Complications
Memorial Sloan Kettering Cancer Center 111
Early research (Phase 1)Study completedNCT00562380
What this trial is testing

AMG-479 in Treating Patients With Advanced Solid Tumors or Non-Hodgkin Lymphoma

Who this might be right for
LymphomaProstate CancerSarcoma+2 more
Amgen 64
Early research (Phase 1)Study completedNCT00049296
What this trial is testing

Thalidomide and Docetaxel in Treating Patients With Advanced Cancer

Who this might be right for
Cancer
Case Comprehensive Cancer Center 26
Testing effectiveness (Phase 2)Active Not RecruitingNCT04718883
What this trial is testing

CD19-targeted CAR T Cells for Relapsed and Refractory (R/R) Mantle Cell Lymphoma

Who this might be right for
Mantle Cell Lymphoma
Shanghai Ming Ju Biotechnology Co., Ltd. 59
Next Page